PHARMACYCLICS INC Free cash flow
- Free cash flow · 12 months (USD): Value $114.56M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2015-03-31..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2015-03-31..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2015-03-31..
- Free cash flow margin · 12 months: Value 14.04%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2015-03-31..
Free cash flow
Overview →Financial period ending 2015-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $114.56M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2015-03-31. $123.39M − $8.83M ≈ $114.56M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2015-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2015-03-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 14.04% | (Operating cash flow − capital spending) / revenue. Period ending 2015-03-31. $114.56M ÷ $816.12M × 100 ≈ 14.04% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2015-03-31. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $123.39M | Cash generated by operating activities. Period ending 2015-03-31. |
| Operating cash flow / net income · 12 months | 1.71× | Operating cash flow / net income. Period ending 2015-03-31. $123.39M ÷ $72.00M ≈ 1.71× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 123.39M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 8.83M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 114.56M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 816.12M USD | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 72.00M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $114.56M | (m) | $123.39M | $8.83M | (m) | $816.12M | (m) | $72.00M | (m) | (m) | 14.04% | 1.71× |
| 2014-12-31 | $169.85M | (m) | $183.77M | $13.92M | (m) | $729.73M | (m) | $86.12M | (m) | (m) | 23.28% | 2.13× |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $128.85M | (m) | $151.30M | $22.44M | (m) | $376.70M | (m) | $137.20M | (m) | (m) | 34.21% | 1.10× |
| 2013-12-31 | $70.45M | (m) | $88.77M | $18.32M | (m) | $260.17M | (m) | $67.01M | (m) | (m) | 27.08% | 1.32× |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $68.79M | (m) | $72.88M | $4.09M | (m) | $164.71M | (m) | $87.80M | (m) | (m) | 41.77% | 0.83× |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $-23.42M | (m) | $-22.27M | $1.15M | (m) | $8.23M | (m) | $-35.20M | (m) | (m) | -284.48% | 0.63× |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $-15.69M | (m) | $-15.47M | $224.00K | (m) | $9.31M | (m) | $-15.02M | (m) | (m) | -168.60% | 1.03× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.